Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
1,340 enrolled
Natural Killer Cells and Bortezomib to Treat Cancer
Phase 1 Completed
35 enrolled
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
Completed
1,892 enrolled
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
Phase 2 Completed
55 enrolled 17 charts
Imaging in MGUS, SMM and MM
Phase 2 Completed
31 enrolled 13 charts
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Phase 1/2 Completed
34 enrolled 18 charts
Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
Phase 1 Completed
8 enrolled 11 charts
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
Phase 3 Completed
1 enrolled 1 chart
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
Phase 2 Completed
19 enrolled 18 charts
Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Completed
12 enrolled
Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
Phase 2 Completed
203 enrolled 25 charts
Vaccine Therapy in Treating Patients With Multiple Myeloma
Phase 2 Completed
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Phase 2 Completed
57 enrolled 22 charts
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
25 enrolled 11 charts
BMT CTN 0702
Phase 3 Completed
758 enrolled 21 charts
BMT CTN 0102
Phase 3 Completed
710 enrolled 19 charts
Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers
Phase 2 Completed
62 enrolled 15 charts
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
Phase 1 Completed
13 enrolled 15 charts
Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)
Phase 2 Completed
52 enrolled 10 charts
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
Phase 1 Completed
71 enrolled
Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)
Phase 2 Completed
47 enrolled 10 charts
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
Phase 2 Completed
45 enrolled 15 charts
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)
Phase 3 Completed
273 enrolled 16 charts
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
Phase 1/2 Completed
43 enrolled 18 charts
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Phase NA Completed
41 enrolled
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
Phase 1 Completed
16 enrolled
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
Phase 1 Completed
30 enrolled 13 charts
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
Phase 2 Completed
16 enrolled 11 charts
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Phase 1/2 Completed
92 enrolled 28 charts
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers
Phase 2 Completed
102 enrolled
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
Phase 1 Completed
110 enrolled
Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase 1 Completed
41 enrolled
Collection of Transplant Stem Cells for Plasma Cell Myeloma
Phase 2 Completed
49 enrolled 17 charts
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
Phase 2 Completed
20 enrolled 10 charts
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Phase 2 Completed
39 enrolled 10 charts
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
Completed
815,000 enrolled
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
Phase 2 Completed
23 enrolled 7 charts
Blood and Marrow Transplant Clinical Research Network
Phase NA Completed
Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Phase 1 Completed
15 enrolled
AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma
Phase 2 Completed
37 enrolled 9 charts
Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Phase NA Completed
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Completed
12 enrolled
FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
50 enrolled
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Phase 1 Completed
93 enrolled
Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma
Phase 1 Completed
50 enrolled
Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
16 enrolled 6 charts
Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2 Completed
44 enrolled 8 charts
Sunitinib in Treating Patients With Relapsed Multiple Myeloma
Phase 2 Completed
13 enrolled 7 charts
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 3 Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
Phase 1 Completed
42 enrolled